Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning
Immunotherapy is a promising strategy for triple-negative breast cancer (TNBC) patients, however, the overall survival (OS) of 5-years is still not satisfactory. Hence, developing more valuable prognostic signature is urgently needed for clinical practice. This study established and verified an effe...
Main Authors: | Lijuan Tang, Zhe Zhang, Jun Fan, Jing Xu, Jiashen Xiong, Lu Tang, Yan Jiang, Shu Zhang, Gang Zhang, Wentian Luo, Yan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1195864/full |
Similar Items
-
Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer
by: Kun Fang, et al.
Published: (2022-11-01) -
Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
by: Qin Zhou, et al.
Published: (2023-08-01) -
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by: Onyinyechi Obidiro, et al.
Published: (2023-06-01) -
Clinical Trials and Current Progress in the Treatment of Triple-negative Breast Cancer
by: LI Linrong, et al.
Published: (2023-01-01) -
The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia
by: Prelog Tomaz, et al.
Published: (2024-02-01)